KIF5B
Basic information
Region (hg38): 10:32009015-32056425
Previous symbols: [ "KNS1" ]
Links
Phenotypes
GenCC
Source:
- disease (Moderate), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- 6 conditions (1 variants)
- Feeding difficulties;Intellectual disability;Severe muscular hypotonia;Fatigable weakness of swallowing muscles (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KIF5B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 42 | 48 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 2 | 2 | 46 | 3 | 1 |
Variants in KIF5B
This is a list of pathogenic ClinVar variants found in the KIF5B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-32015539-T-C | Uncertain significance (Apr 17, 2024) | |||
10-32015558-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
10-32015560-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
10-32015608-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
10-32017183-C-G | not specified | Uncertain significance (Dec 06, 2024) | ||
10-32017293-C-T | not specified | Uncertain significance (Jul 26, 2024) | ||
10-32017339-A-T | Uncertain significance (Oct 17, 2022) | |||
10-32017352-C-A | not specified | Uncertain significance (Sep 20, 2023) | ||
10-32018051-C-A | Uncertain significance (Jul 10, 2024) | |||
10-32018069-T-C | Uncertain significance (May 14, 2024) | |||
10-32018099-A-T | not specified | Uncertain significance (Feb 22, 2024) | ||
10-32018121-G-A | Benign (Oct 10, 2018) | |||
10-32019867-T-C | not specified | Uncertain significance (Oct 24, 2023) | ||
10-32019912-T-C | Brain atrophy;Global developmental delay;Hypoplasia of the corpus callosum;Seizure;Attention deficit hyperactivity disorder | Likely pathogenic (Jan 10, 2016) | ||
10-32021034-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
10-32021058-A-G | not specified | Uncertain significance (May 31, 2023) | ||
10-32021114-C-A | not specified | Uncertain significance (Dec 16, 2022) | ||
10-32021118-T-C | not specified | Uncertain significance (May 27, 2022) | ||
10-32021131-G-A | Uncertain significance (Dec 12, 2023) | |||
10-32022139-C-AA | Uncertain significance (Apr 28, 2023) | |||
10-32022229-T-G | not specified | Uncertain significance (Jul 14, 2023) | ||
10-32022933-T-C | Uncertain significance (Sep 23, 2022) | |||
10-32022996-A-G | not specified | Uncertain significance (May 27, 2022) | ||
10-32023011-T-A | Uncertain significance (May 31, 2024) | |||
10-32023018-T-C | not specified | Uncertain significance (May 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KIF5B | protein_coding | protein_coding | ENST00000302418 | 25 | 47422 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.994 | 0.00573 | 125708 | 0 | 40 | 125748 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.06 | 306 | 498 | 0.615 | 0.0000255 | 6398 |
Missense in Polyphen | 75 | 186.75 | 0.40162 | 2428 | ||
Synonymous | -0.381 | 171 | 165 | 1.04 | 0.00000794 | 1698 |
Loss of Function | 5.94 | 10 | 59.4 | 0.168 | 0.00000328 | 728 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000269 | 0.000268 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000232 | 0.000231 |
European (Non-Finnish) | 0.000196 | 0.000193 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Microtubule-dependent motor required for normal distribution of mitochondria and lysosomes. Can induce formation of neurite-like membrane protrusions in non-neuronal cells in a ZFYVE27-dependent manner (By similarity). Regulates centrosome and nuclear positioning during mitotic entry. During the G2 phase of the cell cycle in a BICD2-dependent manner, antagonizes dynein function and drives the separation of nuclei and centrosomes (PubMed:20386726). Required for anterograde axonal transportation of MAPK8IP3/JIP3 which is essential for MAPK8IP3/JIP3 function in axon elongation (By similarity). {ECO:0000250|UniProtKB:Q2PQA9, ECO:0000250|UniProtKB:Q61768, ECO:0000269|PubMed:20386726}.;
- Pathway
- Dopaminergic synapse - Homo sapiens (human);Endocytosis - Homo sapiens (human);Insulin Signaling;Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;RHO GTPases activate KTN1;Kinesins;Factors involved in megakaryocyte development and platelet production;RHO GTPase Effectors;Signaling by Rho GTPases;Hemostasis;COPI-dependent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;N-cadherin signaling events;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.316
- rvis_EVS
- -0.93
- rvis_percentile_EVS
- 9.55
Haploinsufficiency Scores
- pHI
- 0.573
- hipred
- Y
- hipred_score
- 0.648
- ghis
- 0.624
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.636
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kif5b
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- kif5ba
- Affected structure
- chondrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased occurrence
Gene ontology
- Biological process
- microtubule-based movement;cytoplasm organization;hippocampus development;positive regulation of vesicle fusion;positive regulation of synaptic transmission, GABAergic;stress granule disassembly;positive regulation of insulin secretion involved in cellular response to glucose stimulus;regulation of membrane potential;positive regulation of potassium ion transport;vesicle transport along microtubule;centrosome localization;cellular response to interferon-gamma;plus-end-directed vesicle transport along microtubule;positive regulation of intracellular protein transport;anterograde axonal protein transport;positive regulation of protein localization to plasma membrane;positive regulation of voltage-gated sodium channel activity;anterograde neuronal dense core vesicle transport;retrograde neuronal dense core vesicle transport
- Cellular component
- microtubule organizing center;cytosol;kinesin complex;microtubule;membrane;vesicle;ciliary rootlet;axonal growth cone;phagocytic vesicle;perinuclear region of cytoplasm;axon cytoplasm
- Molecular function
- microtubule motor activity;protein binding;ATP binding;microtubule binding;JUN kinase binding;ATPase activity;identical protein binding;cadherin binding;microtubule lateral binding